Oncology Central

Highlights from the latest articles in pharmacogenomics research


Evaluation of: Egberts F, Bergner I, Krüger S et al. Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas Ann. Oncol. 25(1), 246–250 (2014).

In 1–8% of metastatic melanoma the primary tumor cannot be found. Although 90% of melanomas are of cutaneous origin, other origins exist. It has been proposed that the mutational status (i.e., BRAF, NRAS, KIT) can distinguish between different types of melanoma. Sixty-six melanomas of unknown primary origin from 44 melanoma patients were genotyped in order to identify the origin of the primary tumor and to evaluate the prognostic significance of mutational status.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.